Acromegaly Update podcast

Acromegaly Update — Tuesday September 15, 2026

0:00
7:00
Rewind 15 seconds
Fast Forward 15 seconds
It's a quiet week for acromegaly-specific research — just one review paper worth flagging — but rare disease industry news was busy, headlined by Scholar Rock's first-ever muscle-targeted SMA approval and a rough week for two RNA-based rare disease programs at Novartis.

More episodes from "Acromegaly Update"